Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil for pain reduction in disc herniation surgery
IRCT20141209020258N108Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herniated disc comparing Dexmedetomidine and acetaminophen, Remifentanil and acetaminophen and Placebo and acetaminophen (3 arms). Primary endpoints: pain and relaxation. Started Dec 2018; status: completed.
02
Drugs
dexmedetomidineremifentanilacetaminophen
03
Conditions
herniated disc
Beyond the preview
Go deeper on IRCT20141209020258N108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N108.